Ambu A/S (OTCMKTS:AMBBY) Upgraded by Handelsbanken to “Outperform”

Handelsbanken upgraded shares of Ambu A/S (OTCMKTS:AMBBYFree Report) from a market perform rating to an outperform rating in a research note issued to investors on Tuesday, FlyOnTheWall reports.

Ambu A/S Price Performance

Ambu A/S stock opened at $12.07 on Tuesday. The firm’s 50 day simple moving average is $14.53 and its 200-day simple moving average is $15.00. Ambu A/S has a fifty-two week low of $8.08 and a fifty-two week high of $16.85.

Ambu A/S Company Profile

(Get Free Report)

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. It provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics. The company offers endoscopy products, such as bronchoscopes and monitors; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.

Recommended Stories

Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.